SYS6053 (emicizumab biosimilar)
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 04, 2026
Emicizumab injection (SYS6053) obtains clinical trial approval in china
(CSPC Press Release)
New trial • Hemophilia A
1 to 1
Of
1
Go to page
1